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Total syntheses of natural products containing
spirocarbocycles
Laura K. Smith* and Ian R. Baxendale
The structures of natural products from a variety of sources contain spirocycles, two rings that share a
common atom. The spiro motif is ﬁnding increasing inclusion in drug candidates, and as a structural com-
ponent in several promising classes of chiral ligands used in asymmetric synthesis. Total syntheses of pro-
ducts containing all-carbon spirocycles feature several common methods of ring closure which we
examine in this review.
1. Introduction
Natural products have been an invaluable source of medicines
and other resources throughout history. In recent years, the
search for novel compounds has moved from the land to the
sea, concentrating on marine organisms rather than terrestrial
species. There are several ways of classifying such compounds:
by genus of their source, by physiological eﬀect, or by a
common structural element such as their carbon skeleton.
This review will focus on natural products containing the spiro
motif. Spiro compounds possess two or more rings which
share only one common atom, with the rings not linked by
a bridge.1
Spiro-containing compounds have been isolated from a
wide range of biological sources, from plants to frogs to
marine sponges. The shift from earth to water in search of
compounds is mirrored here. Selected examples of such com-
pounds are shown below (Fig. 1). Spirocycles containing hetero-
atoms, such as the spirooxindoles, are well-known in nature,
and there have been several reviews on these species.2,3 One of
the earliest isolated spiro natural products was β-vetivone,
extracted from vetiver oil in 1939 by Pfau and Plattner.4
However, for many years its structure was believed to be hydro-
azulenic (1.6) rather than a spiro[4.5]decane (1.7), an error
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which was only rectified by its total synthesis by Marshall et al.
in 1968.5,6
The spiro motif is becoming more prevalent as a template
in drug discovery, and has been the subject of a recent review.7
Spiro rings of diﬀerent sizes convey both increased three-
dimensionality for potential improved activity, and novelty for
patenting purposes. Two examples of marketed drugs contain-
ing spirocycles are spironolactone (1.2) and griseofulvin (1.5,
Fig. 1). Both are on the World Health Organisation’s list of
essential medicines; spironolactone is a diuretic and anti-
hypertensive drug, whilst griseofulvin is an anti-fungal agent.
An additional important application of spiro compounds is
in asymmetric synthesis. Enantioselectivity in organic reac-
tions can be achieved through the use of chiral ligands, such
as BINOL (1.8) or cinchona alkaloids (1.9, Fig. 2). Some spiro-
cycles, such as the spirobiindane SPINOL (1.10), belong to a
class of privileged chiral ligands which show particular
promise.8 The increased rigidity and restricted rotation at the
spiro centre can assist in improving enantiomeric excess in
asymmetric reactions.
The asymmetric synthesis of quaternary carbon centres is
extremely challenging,9 with the stereocontrolled preparation
of products containing such spiroatoms10–12 conveying
additional diﬃculty. Enantioselective syntheses of spirocyclic
ligands utilise several construction methods, such as alkyl-
ation, radical cyclisation, rearrangements, cycloaddition reac-
tions, cleavage of bridged ring systems and the use of
transition metal catalysts.13 Several ring-closing strategies are
common in the synthesis of spirocarbocycle-containing
natural products, and these will be discussed in this review.
Examination of the syntheses of these compounds will be first
by reaction type of the spirocycle-forming step, followed by
increasing ring size, from [2.5] through to [5.5] (Table 1). Not
all ring sizes are represented in the natural world, nor have all
spiro-containing natural products been the target of organic
synthesis. Some reaction types have not been included in this
article, for example the Wittig reaction.
Some of the earliest-discovered and best-studied com-
pounds such as the aforementioned β-vetivone have been syn-
thesised by several of these methods. The field has matured
significantly since the 1970s, when many of the structures of
these spiro compounds were elucidated. Syntheses of these
compounds span the last fifty years, and so not all of the orig-
inal articles were published in English, but where relevant,
have been translated and summarised here. In general, newer
spirocyclisation methods tend to be both more eﬃcient and
are conducted enantioselectively. For example, Diels–Alder
spirocyclisations of the acoranes were first attempted in 1975
and re-examined in 2013, where one isomer was selectively syn-
thesised rather than the full range of four isomers (Scheme 1).
Reports from the last five years indicate that new spiro
natural products are still being isolated and synthesised. Total
syntheses of some compounds isolated many years ago were
achieved using the less sophisticated methodologies available
at the time, but there has been much improvement of these
older methods by the application of more modern processing
techniques and understanding. It may also be beneficial to
apply some of the approaches recently developed in the
enantioselective synthesis of chiral ligands to the synthesis of
natural products. Several new natural product compounds
have been recently identified that would benefit from an
eﬃcient preparative synthesis. Cyanthiwigin AC (Fig. 3), iso-
lated from the marine sponge Myrmekioderma styx,14 is such
an example. The cyanthiwigins exhibit a broad range of bio-
logical activity, including inhibition of human immunodefi-
ciency virus and Mycobacterium tuberculosis, and cytotoxicity
against human primary tumour cells.15 The first and only total
synthesis of (+)-cyanthiwigin AC was achieved in 13 steps and
2% overall yield.16 Other compounds have also shown interest-
ing preliminary biological activity ranging from anti-bacterial
to anti-fouling activity but further investigation is hampered
Fig. 1 Natural products and drugs containing spirocycles.
Fig. 2 Selected privileged ligand classes.
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Table 1 List of the natural products covered in this review, in order of increasing ring size then alphabetically
Natural product Structure Spiro Section Natural product Structure Spiro Section
Illudin M [2.5] 4 Anhydro-β-rotunol
(2005)
[4.5] 2
Illudin S [2.5] 4 Axenol (2002, 2007) [4.5] 4, 6
(−)-Acutumine
(synthesised in 2009)
[4.4] 7 Axisonitrile-3 (2009) [4.5] 6
Ainsliadimer A
(2010)
[4.4] 5 Bilinderone (2011) [4.5] 7
Vannusal A (R = Ac) [4.4] 2 Cannabispirenone A:
CvC, R1 = Me, R2 = H;
B: CvC, R1 = H, R2 =
Me
[4.5] 2
Vannusal B (R = H)
(2009)
Cannabispirone (C–C,
R1 = Me, R2 = H)
(1981, 1982, 1984)
Acorenone (1978,
1982, 2011)
[4.5] 3, 4, 7 Colletoic acid (2013) [4.5] 5
Acorenone B (1975,
1978)
[4.5] 2, 3 Erythrodiene (1997,
1998)
[4.5] 2, 6
Acorone (1975, 1977,
1978, 1996, 2007)
[4.5] 2, 4, 5,
6
Gleenol (2002, 2007,
2009)
[4.5] 4, 6
Agarospirol (1970,
1975, 1980, 1995,
2006)
[4.5] 2, 3, 6,
7
Gochnatiolide A
(R = α-OH)
[4.5] 5
Gochnatiolide B
(R = β-OH)
Gochnatiolide C
(R = α-H)
(2013)
Ainsliadimer B
(2013)
[4.5] 5 Hinesene (2R,5S,10S)
(2004)
[4.5] 3
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Table 1 (Contd.)
Natural product Structure Spiro Section Natural product Structure Spiro Section
Hinesol (1970, 1973,
1980, 1995, 2004,
2006, 2007)
[4.5] 3, 6, 7 Spirojatamol (1997,
1998)
[4.5] 2, 6
Isoacorone (1975,
2000, 2007, 2008)
[4.5] 2, 4, 5,
6
Spirolaurenone (1982) [4.5] 3
Lubimin (1984) [4.5] 3 Trichoacorenol (2011) [4.5] 4
Lubiminol (1996,
1998)
[4.5] 7 (+)-Vitrenal (1982,
1986)
[4.5] 2, 3
Oxylubimin (1984) [4.5] 3 α-Acoradiene: [4.5] 2, 4, 7
L (1R,4S,5S)
R (1S,4R,5R)
(1983, 2001, 2004)
Premnaspirodiene
(2R,5S,10R) (2004)
[4.5] 3 α-Acorenol (2007) [4.5] 4, 6
Proaporphines: [4.5] 7 α-Vetispirene (1973,
1976, 1985, 2004,
2006, 2007)
[4.5] 2, 3, 6,
7Pronuciferine
(R1 = Me, R2 = H)
Orientalinone
(R1 = Me, R2 = OMe)
Kreysiginone
(R1 = H, R2 = OMe)
(1971, 1972, 1978)
Sequosempervirin A
(2007)
[4.5] 4 β-Acoradiene (1975) [4.5] 5
Solavetivone (1984) [4.5] 3 β-Acorenol (2007) [4.5] 4, 6
Spirocurcasone
(2013, 2014)
[4.5] 3, 4 β-Vetispirene (1973) [4.5] 3
Review Organic & Biomolecular Chemistry
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by the inability to isolate or synthesise suﬃcient quantities.
The ritterazines are such a class of compounds: they are a
family of 26 steroidal alkaloids of which 11 contain a spiro-
carbocycle in addition to the spiroketal shared by all ritter-
azines.17 They possess potent cytotoxic activity against
apoptosis-resistant malignant cell lines but research has been
limited by the small amounts of material successfully isolated
from naturally occurring sources, so eﬀorts have focussed on
their total synthesis. There have been several published synth-
eses of the other 15 ritterazines and derivatives, but at the
time of writing there has not yet been a published total syn-
thesis of the spirocarbocycle-containing ritterazines.
Taber et al. have come the closest to synthesising ritterazine
N (1.20, Scheme 2) and related analogues18,19 by assembling a
ritterazine N precursor. The final planned aldol cyclocondens-
ation failed, but an alternative route via ozonolysis of an
alkene followed by treatment with base successfully gave the
related compound bis-18,18′-desmethylritterazine N (1.23).19,20
As this review aims to summarise the progress in the field,
but also to identify areas for improvement, where natural pro-
ducts have been synthesised by more than one strategy, the
methods will be compared.
2. Aldol reaction
The aldol reaction is a powerful carbon–carbon bond forming
reaction.21 Stereochemical control is possible through the
use of chiral aldehyde starting materials, or chiral auxiliaries.
The asymmetric reaction can also be performed catalytically
through the use of chiral Lewis acids.22 This approach has
been particularly eﬀective in the synthesis of various natural
product spirocarbocycles as illustrated below.
2.1 Vannusals A and B
Vannusals A and B are triterpenes with an unusual C30 back-
bone, comprising seven rings and thirteen chiral centres, three
of which are quaternary. They were isolated from the tropical
zooplankton Euplotes vannus, and their biosynthesis is thought
Table 1 (Contd.)
Natural product Structure Spiro Section Natural product Structure Spiro Section
β-Vetivone (1968,
1973, 1984, 2006,
2007)
[4.5] 2, 3, 6,
7
Laurencenone B
(2008)
[5.5] 4
γ-Acoradiene (1973) [4.5] 5 Laurencenone C
(2010)
[5.5] 2, 4
δ-Acoradiene (1973) [4.5] 5 Majusculone (2007,
2011)
[5.5] 2, 3
Linderaspirone A
(2011)
[4.3.4.3] 7 α-Chamigrene (1991,
2006)
[5.5] 3, 4
Elatol (2008) [5.5] 4 β-Chamigrene (2006,
2008)
[5.5] 4
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to proceed from a squalene-type precursor (Fig. 4), via several
possible routes.23
The originally assigned structures for the vannusals were
incorrect, and the true structures were only established follow-
ing the total synthesis eﬀorts of the Nicolaou group.24 The
fused polycyclic carbon framework was assembled by an intra-
molecular spirocyclisation via a Mukaiyama-type aldol reac-
tion25,26 (Scheme 3).
The above methodology was used in the total syntheses of
the original incorrect vannusal B structure,27 as well as the
resyntheses of the true vannusals A and B.24,28–30
2.2 Acoranes: α-acoradiene, acorone, isoacorone and
acorenone B
The acoranes are a group of highly-oxygenated sesquiterpenes
containing a spiro[4.5] core. They have been isolated from a
variety of sources,31–33 including sweet flag Acorus calamus, the
Scheme 1 Comparing the synthesis of acoranes by the Diels–Alder
reaction.
Fig. 3 Structures of cyanthiwigin AC and ritterazine N.
Scheme 2 Attempted syntheses of ritterazine N. Bis-18,18’-desmethyl-
ritterazine N was obtained as a single diastereomer in high yield.
Fig. 4 Proposed link between the structures of vannusals and
squalene.
Scheme 3 Mukaiyama aldol reaction in the synthesis of vannusal A.
Review Organic & Biomolecular Chemistry
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essential oils of the woods of Juniperus rigida and J. chinensis,
and Australian sandalwood oil from Santalum spicatum.
(±)-Acorone was synthesised in 1977 by the Dolby group,
starting from 4-methyl-3-cyclohexene carboxaldehyde and
using an intramolecular base-catalysed aldol cyclisation34
(NaOEt/EtOH). A similar method reported by Martin et al. in
1978 used an aldol cyclocondensation to also synthesise
racemic acorone35 (Scheme 4).
In addition, in 1996 Srikrishna et al. performed a formal
total synthesis of (±)-acorone36 using an intramolecular
aldol condensation of 1,4-cyclohexanedione. (±)-Acorone and
(±)-isoacorone were later formally synthesised by the same
group using a Claisen rearrangement-based methodology.37
Two enantiomers of the sesquiterpenoid α-acoradiene
occur naturally: one is found in juniper wood, and the other is
a pheromone of the broad-horned flour beetle. The structure
of the beetle α-acoradiene was originally thought to be the
(1R,4R,5S) enantiomer, which has been synthesised by ring-
closing metathesis (see below). (1S,4R,5R)-α-Acoradiene was
synthesised from (S)-(−)-pulegone in 10 steps and 16% overall
yield38 (Scheme 5) by Mori et al. in 2004. The key step was the
aldol condensation of a 1,5-diketone to form the 6-membered
ring.
Acorenone B has been synthesised under basic conditions
to form the spirocycle39 in high yield (Scheme 6) by Trost et al.
in 1975.
2.3 Spirovetivanes: agarospirol, β-vetivone, α-vetispirene and
anhydro-β-rotunol
The spirovetivanes are sesquiterpenes with a spiro[4.5] core.
They include metabolites and phytoalexins, compounds pro-
duced when a species is subjected to stress such as pathogenic
attack.40 Vetiver oil from Vetiveria zizanioides contains several
spirovetivanes, including β-vetivone,4 α-vetispirene and β-vetis-
pirene.41 As stated above, for many years, the structure of
β-vetivone was thought to be hydroazulenic but this was
revised to the spiro[4.5]decane in 1968.5,6
Following on from this work by Marshall and Johnson,
Wenkert et al. used methanolic KOH to eﬀect a basic aldol cycli-
sation of a key intermediate in the synthesis of β-vetivone.42 The
reaction proceeded in 95% yield, as part of a formal total syn-
thesis requiring 8 steps to reach the preliminary compound.
A tandem Michael-aldol condensation was used by Hutch-
ins et al. in 1984 to synthesise racemic β-vetivone43 (Scheme 7)
in a very short and eﬃcient synthesis.
Starting from a spiro[5.5]acetal, (−)-agarospirol, a metabolite
isolated from agarwood oil,44 was synthesised in 1975 via a 1,6-
dicarbonyl and base to generate the α,β-unsaturated ketone.45
Ten years later, α-vetispirene was synthesised by Balme
using a related intramolecular spirocondensation with a 1,5-
dicarbonyl under basic conditions46 (Scheme 8).
Anhydro-β-rotunol is a phytoalexin spirovetivadiene isolated
from infected potato tubers.47 In 2005 Srikrishna et al. per-
formed an enantioselective synthesis of (+)-anhydro-β-rotunol
starting from (R)-carvone in 13 steps and 15% overall yield48
(Scheme 9). The spirocyclisation step involved a regioselective
intramolecular aldol condensation of a keto-aldehyde, remini-
scent of Balme’s synthesis of α-vetispirene. Other conditions
were attempted, but piperidine in AcOH was found to be the
most successful.
Scheme 4 Base-catalysed cyclisation in the synthesis of (±)-acorone
and (±)-isoacorone. No mention was made of the dr of intermediate
2.11.
Scheme 5 Aldol condensation of 1,5-diketone 2.15 to form the spiro
intermediate 2.16 in the synthesis of α-acoradiene.
Scheme 6 Aldol reaction in the synthesis of acorenone B.
Organic & Biomolecular Chemistry Review
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2.4 Erythrodiene and spirojatamol
Erythrodiene and spirojatamol are sesquiterpenes that share a
common spirobicyclic [4.5]decane skeleton. (−)-Erythrodiene
was isolated from a Caribbean encrusting coral, whereas
(+)-spirojatamol was isolated from a Himalayan flowering
plant. Erythrodiene and spirojatamol have been formally syn-
thesised from N-cyclohexyl-4-isopropylcyclohexanimine49 by
Ihara et al. in 1997. The key spirocyclisation step was a tandem
intramolecular Michael-aldol reaction of a ketoacetal with
Me3SiI/(Me3Si)2NH (Scheme 10).
Forsyth et al. have used spirocarbomercuration to syn-
thesise erythrodiene and spirojatamol;50,51 more recently,
Oppolzer et al. have used a Pd-catalysed allylzincation52 and
Renaud et al. a thiophenol-mediated spirocyclisation.53
2.5 Vitrenal
(+)-Vitrenal is a sesquiterpenoid and a potent plant growth
inhibitor.54 The unnatural enantiomer, (−)-vitrenal, has been
synthesised from (+)-3-carene55 by Ito et al. in 1986. The key
sequence is a one-pot deacetalisation-aldol condensation,
which is preceded by a stereoselective Claisen rearrangement
(Scheme 11). It showed weaker plant growth inhibition than
the natural enantiomer.
2.6 Cannabispirans: cannabispirenones A and B and
cannabispirone
A variety of spiroindane products have been isolated from the
marijuana plant, Cannabis sativa.56–62 They are structurally
related to some synthetic oestrogenic-potentiating agents and
Scheme 9 Aldol condensation in the synthesis of anhydro-β-rotunol.
Scheme 8 Basic aldol condensation in the synthesis of α-vetispirene.
Scheme 7 Tandem Michael-aldol condensation in the synthesis of
β-vetivone.
Scheme 10 Aldol reaction during the synthesis of erythrodiene and
spirojatamol. The diastereomers 2.35–2.38 were separable by column
chromatography.
Review Organic & Biomolecular Chemistry
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so may show similar oestrogenic activity to marijuana.59
Crombie et al. used KOH to intramolecularly close the spiro
ring of several cannabispirans63,64 (Scheme 12).
Cannabispirone was synthesised by treating an aldehyde
and methyl vinyl ketone with tBuOK65 (Scheme 13) by El-Feraly
et al. in 1981.
Cannabispirenone A was asymmetrically synthesised by
Natale et al. in 1984 from 3,5-dimethoxyaniline in 11 steps,
using an enamine and methyl vinyl ketone followed by hydro-
lysis to form the spiro centre66 (Scheme 14).
Similarly, cannabispirenone B was synthesised by Novak
et al. in 1982.67 Aldehyde 2.51 was transformed to the piper-
idine enamine, before it was reacted with methyl vinyl ketone
followed by hydrolysis and aldol cyclisation. The increased
diﬃculty in the synthesis of cannabispirenone B over A lay in
the selective ether cleavage of the less sterically hindered aryl
methoxy group. Previously this had only been possible using
BBr3, which gave low yields and led to the formation of insolu-
ble tars. Ten reagents were considered by the authors, of
which only LiI in 2,4,6-trimethylpyridine was successful in
56% conversion and 82% yield.
2.7 Chamigrenes: majusculone and laurencenone C
The chamigrene family is a group of over 100 sesquiterpene
natural products that contain a spiro[5.5]undecane core.
Examples include majusculone and laurencenone C.68,69 Some
chamigrenes are halogenated, and the group shows diverse
biological activity.
Zhu et al. synthesised racemic laurencenone C in 2010, and
the key step was a base-catalysed aldol condensation70
(Scheme 15). The full sequence involved 11 steps with an
overall yield of 17%.
Racemic majusculone also was synthesised from ethyl cyano-
acetate in 15 steps71 (Scheme 16) by Zhu et al. in 2011. The
key step in this particular synthesis was the tandem oxidation-
aldol condensation of the diol to the keto aldehyde which
underwent base-mediated cyclisation.
3. Acid and base promoted
spirocyclisation
Acids or bases can be used in a wider range of cyclisation reac-
tions than just to promote the aldol reaction. For example, the
Scheme 11 One-pot deacetalisation-Aldol condensation in the syn-
thesis of (−)-vitrenal. Intermediate 2.42 was present as a 1 : 1 mixture of
geometrical isomers, which were only separable by gas chromato-
graphy. Both isomers gave the same acid (2.43).
Scheme 12 Basic aldol reaction in the spirocyclisation of cannabispire-
none A.
Scheme 13 Spirocyclisation step in the synthesis of cannabispirone.
Scheme 14 Aldol condensation in the synthesis of cannabispirenone A.
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related Robinson annulation and Prins cyclisation have been
used to synthesise natural products containing spirocarbo-
cycles as described below.
3.1 Acoranes: acorenone, acorenone B and α-acorenol
(±)-Acorenone B has been synthesised from (±)-camporone.72
Formic acid was used to activate the allylic alcohol to attack by
an alkene via an allylic cation to form the spiro centre
(Scheme 17).
No mention was made of stereochemistry or diastereo-
selectivity in the original 1975 paper and thus this method
may be less eﬀective than the cyclisation in base which was
described above.
In 1976, White et al. started from (R)-(+)-limonene to syn-
thesise (−)-acorenone B in 11 steps.73 The key step was an acid-
catalysed ring-opening of a cyclopropane to reveal the spiro-
[4.5]decanone (Scheme 18).
If lithium in liquid ammonia was used to perform a reduc-
tive scission of the cyclopropane bond, inversion of the stereo-
chemistry of the methyl group was observed.
Pesaro et al. used a Robinson annulation in 1978 to syn-
thesise both (−)-acorenone and (−)-acorenone B, in 4 steps
starting from (+)-p-menth-1-ene74 (Scheme 19).
The reaction gave the key spiro intermediate in low yield,
with the stereoselectivity of the reaction controlled by the iso-
propyl and methyl groups, which direct the electrophilic
addition of the methyl vinyl ketone to the less hindered face.
More recently, Sakai et al. used a Lewis acid to eﬀect a one-
pot transformation to a spiro compound en route to racemic
acorenone B (Scheme 20).75 The mechanism is thought to
proceed via an aldol condensation, followed by hemiacetalisa-
tion and finally a Grob-type fragmentation to realise the
intermediate.
In 2014, Chen et al. used the reduction of a cyclohepta-
triene to trigger an acid-induced rearrangement in the formal
synthesis of α-acorenol (Scheme 21).76
Scheme 16 Oxidation followed by cyclisation in the synthesis of
(±)-majusculone.
Scheme 15 Aldol cyclisation in the synthesis of laurencenone C.
Scheme 18 Ring-opening of an intermediate 3.5 in the synthesis of
(−)-acorenone B.
Scheme 17 Treatment of an intermediate with formic acid in the syn-
thesis of acorenone B. The dr were not stated, but the product was iso-
lated as a single diastereomer via preparative TLC.
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3.2 Spirovetivanes: agarospirol, hinesol, β-vetivone,
α-vetispirene and β-vetispirene
Acetal formation followed by reduction and treatment with
acid was used to form the molecules hinesol, β-vetivone, and
α- and β-vetispirenes77,78 (Scheme 22). These syntheses were
published in a series of articles from Yamada et al. in 1973.
A Lewis acid-catalysed Prins cyclisation was used by
McCurry et al. in 1973 in the synthesis of racemic β-vetivone
and β-vetispirene79 (Scheme 23).
Of the four possible diastereomers, the two shown in
Scheme 23 constituted 97% of the reaction mixture. The mech-
anism is thought to proceed via a 6-membered ring transition
state.
Deslongchamps et al. have synthesised racemic agarospirol
and hinesol from a keto ester.80,81 The spirocycle was
formed by treatment of a cyclopropane intermediate with acid
(Scheme 24).
The intermediate is thought to undergo facile cyclopropane
ring-opening under acid conditions via the enol.
Spiroannulation of 5-methyl-1,3-cyclohexanedione with an
alkyl halide in base was used to synthesise β-vetivone82
(Scheme 25) by Stork et al. in 1973.
A similar method was used by Markó et al. in 2004 to form
racemic agarospirol, hinesol and α-vetispirene. A spiro di-
ketone was formed by condensation of a silyl enol ether and
an ortho ester to form a β-ketoketal followed by base-catalysed
intramolecular cyclisation83 (Scheme 26).
In 1988, Posner et al. used a tandem oxidation-acid-
promoted cyclisation in the third asymmetric total synthesis of
(−)-β-vetivone (Scheme 27).84
Acidic or basic conditions are commonly employed in the
key cyclisation step of (±)-hinesol.85,86 A base-catalysed reverse
Prins reaction was used by Marshall et al. in 197087
(Scheme 28).
Scheme 20 Three-step procedure in the synthesis of acorenone B.
Scheme 19 Treatment of an aldehyde with methyl vinyl ketone in base
in the synthesis of (−)-acorenone and (−)-acorenone B.
Scheme 21 Reduction and acid-induced rearrangement in the syn-
thesis of α-acorenol.
Scheme 22 Three-step sequence in the synthesis of β-vetispirene.
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3.3 Spirovetivadienes: solavetivone, lubimin, oxylubimin,
premnaspirodiene and hinesene
Solavetivone is a spirovetivadiene phytoalexin produced by
tobacco plants infected with the tobacco mosaic virus.88–91
Lubimin and oxylubimin are two of several stress metabolites
Scheme 24 Treatment of an intermediate with acid in the synthesis of
hinesol.
Scheme 25 Spiroannulation in base during the synthesis of β-vetivone.
Scheme 23 Prins cyclisation followed by chair-chair interconversion in
the synthesis of β-vetivone. Diastereomers 3.25 and 3.26 were separable,
but the dr was not stated.
Scheme 26 Base-catalysed intramolecular cyclisation during the syn-
thesis of agarospirol. The de of intermediate 3.45 was >95%.
Scheme 27 Oxidation then cyclisation in the synthesis of β-vetivone.
Scheme 28 Basic conditions for the spirocyclisation step during the
synthesis of hinesol.
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produced by fungally-infested white potato tubers.92,93
Premnaspirodiene and hinesene are diastereomers:
(−)-premnaspirodiene is the (2R,5S,10R)-isomer whereas hine-
sene has the (2R,5S,10S) configuration.
Racemic solavetivone was synthesised through a Diels–
Alder reaction followed by π-cyclisation85 (Scheme 29) by
Murai et al. in 1984. The starting material was 3,5-dimethyl-
anisole and the procedure required 12 steps to give the
product in 3% overall yield. The Murai group used this
methodology to synthesise lubimin and oxylubimin in a series
of follow-up articles.94,95
Other conditions attempted for the π-cyclisation were
unsuccessful, including using SnCl4 in DCM at −78 °C, acetic
acid at 110 °C and formic acid at 50 °C.
Premnaspirodiene and hinesene have both been syn-
thesised from α-santonin by Pedro et al. in 2004.96 The key
step was an acid-promoted rearrangement of the carbon skel-
eton (Scheme 30) via a tertiary carbocation formed by ring-
opening of the epoxide.
3.4 Vitrenal
Takahashi synthesised racemic vitrenal in 12 steps and 7%
overall yield from the monoterpene piperitenone97 in 1982.
The key step was an acid promoted acetal hydrolysis and enol
ether trapping (Scheme 31).
3.5 Spirolaurenone
Spirolaurenone is a bromine-containing sesquiterpenoid98
based upon the spirolaurane skeleton.99
Total synthesis of (±)-spirolaurenone proceeded from a
bromohydrin of homogeranonitrile in 13 steps and 2% overall
yield100 as described in 1982 by Murai et al. The key step was
the cleavage of a cyclopropane ring under acidic conditions to
give a mixture of endo and exo alkenes which were separated
by preparative HPLC (Scheme 32). The endo isomer was used
to reach the natural product.
3.6 Chamigrenes: α-chamigrene and majusculone
Unlike its halogenated derivatives, α-chamigrene was isolated
from the five-flavour berry, Schisandra chinensis, rather than a
marine organism. Racemic α-chamigrene was synthesised by
Canonne et al. in 1991 by intramolecular enolate alkylation
promoted by KH101 (Scheme 33).
The first enantioselective synthesis of (+)-majusculone was
achieved by alkylidene carbene insertion promoted by
KHMDS102 (Scheme 34) as described by Taber et al. in 2007.
Scheme 29 Oxalic acid-induced cyclisation in the synthesis of
(±)-solavetivone.
Scheme 30 Acid-promoted rearrangement of the carbon skeleton in
the synthesis of premnaspirodiene.
Scheme 31 Acid-catalysed hydrolysis in the synthesis of (±)-vitrenal.
Scheme 32 Spirocyclisation step in the synthesis of spirolaurenone.
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α-Elimination generated the carbene which inserted into a
C–H bond shown in red to give the spirocycle. An alkyne by-
product from the 1,2-rearrangement was also observed, shown
in blue. Concerns over the ability of the carbene to insert into
the deactivated, congested methine were not realised.
3.7 Spirocurcasone
Spirocurcasone is a diterpenoid with a novel carbon skeleton,
isolated from Jatropha curcas.103 A high-yielding one-pot semi-
synthesis of (+)-spirocurcasone from the natural products cur-
casones A and B has been reported very recently by Qin et al.
in 2014 (Scheme 35).104
In the absence of a metal, the TMEDA is thought to act as a
base. Various conditions were screened, and MeOH was found
to give higher conversions of the starting material over toluene
or DCM, and the relatively mild temperature of 50 °C was
more eﬀective than 90 °C or reflux.
4. Ring-closing metathesis
Spirocarbocycles can be synthesised using a variety of metal
complexes.105 Ring-closing metathesis106,107 typically uses a
ruthenium-based catalyst such as Grubbs’ I or Grubbs’ II to
react two terminal alkenes intramolecularly to give an alkene
and ethene. Kotha et al. have comprehensively reviewed the
synthesis of spirocyclics by ring-closing metathesis in 2003.108
4.1 Illudins
The illudins are sesquiterpenoids isolated from fungi, includ-
ing the highly poisonous Jack-o′ lantern mushroom, Omphalo-
tus illudens.109–111 The illudins themselves are extremely toxic.
Illudins M and S show potent cytotoxic activity in vitro, but are
much less eﬀective in vivo.112,113 There has been considerable
work towards developing anti-cancer derivatives, which are
now in clinical trials. These include bicyclic and isomeric ana-
logues of illudin M,114 acylfulvene and hydroxymethyl-
acylfulvene115,116 (Fig. 5). The latter is now in Phase II clinical
trials against ovarian, prostate, and gastrointestinal cancers.117
The illudin core has been synthesised by Movassaghi et al.
using an enyne ring-closing metathesis cascade118 (Scheme 36)
in 2009.
Scheme 33 Spirocyclisation step in the synthesis of α-chamigrene.
Scheme 34 Spirocyclisation in the synthesis of (+)-majusculone.
Scheme 35 Use of TMEDA in the synthesis of spirocurcasone.
Fig. 5 Acylfuvene, hydroxymethylacylfulvene and illudins M and S.
Scheme 36 Enyne ring-closing metathesis in the synthesis of the
illudin core.
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With Grubbs’ II catalyst, conversion to the desired product
was 90% by 1H NMR spectroscopy, whereas with Grubbs’ I
catalyst the conversion was only 25% to an unwanted side-
product that contained a five-membered ring (Scheme 37).
Illudins M and S have also been previously synthesised
by Matsumoto et al., using a basic aldol ring-closing
reaction.119,120
4.2 Acoranes: trichoacorenol, α-acorenol, β-acorenol,
acorone, isoacorone, acorenone and α-acoradiene
Trichoacorenol is a sesquiterpenoid121 produced by the fungi
Trichoderma koningii and T. harzianum.121,122 The unnatural
enantiomers (−)-trichoacorenol and (−)-acorenone have both
been synthesised from (+)-(R)-pulegone122 by Dickschat et al.
in 2011. The key step was a ring-closing metathesis which
occurred in moderate yield for such a transformation
(Scheme 38).
α-Acorenol and β-acorenol were synthesised starting from
cyclohexan-1,4-dione in 7 steps and 67% overall yield33 by Srik-
rishna et al. in 2007. The key steps were an Ireland–Claisen
rearrangement and ring-closing metathesis (Scheme 39). The
same methodology had previously been applied to the formal
syntheses of (±)-acorone and (±)-isoacorone.123
The (1R,4R,5S) enantiomer of α-acoradiene has been syn-
thesised by Mori et al. in a 14 step sequence, using Grubbs’
I catalyst in the key spirocyclisation (Scheme 40).124
The stereochemistry of the product formed did not match
the stereochemistry of the broad-horned beetle pheromone,
thus disproving the originally proposed structure and identify-
ing the pheromone as (1S,4R,5R)-α-acoradiene.38
4.3 Spiroaxanes: axenol and gleenol
Axenol and gleenol are enantiomeric sesquiterpenes sharing
the spiroaxane skeleton. They have both been isolated from
the Eurypon marine sponges, but (−)-gleenol has also been
found in a variety of coniferous trees, including Picea glehnii,
P. koraiensis, Criptomeria japonica and Juniperus oxycedrus.
Axenol has not been found to exhibit biological activity, but
(+)-gleenol possesses termiticidal and anti-helmintic activities,
as well as regulating the growth of plant seeds.
Scheme 37 Enyne ring-closing metathesis in the synthesis of the
illudin core to give an unwanted side-product.
Scheme 38 Ring-closing metathesis during the synthesis of
(−)-trichoacorenol and (−)-acorenone.
Scheme 39 Ring-closing metathesis in the synthesis of (±)-α-acorenol
and (±)-β-acorenol.
Scheme 40 Ring-closing metathesis in the synthesis of α-acoradiene.
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(+)-Axenol and (−)-gleenol have been synthesised by Spitz-
ner et al., using an organometallic domino reaction, with an
unusual combination of methylenation followed by ring-
closing metathesis125,126 (Scheme 41). The first step in the syn-
thesis was a Michael addition with methyl vinyl ketone,127 fol-
lowed by selective methylenation with the Kauﬀmann
molybdenum complex which was generated in situ from
MoOCl3(THF)2.
128 A mixture of inseparable isomers was
formed in the ratio 2 : 1, of which the major (R)-isomer (4.22)
was the desired product. Grubbs’ I catalyst was added to the
crude reaction mixture in a one-pot reaction to give epimers of
the spiroketone 4.23.
A McMurry coupling was also directly attempted on the tri-
carbonyl, but the spiroketone product was not observed by
GC-MS analysis.
Kobayashi et al. synthesised (−)-axenol in 2015 using ring-
closing metathesis (Scheme 42).129 The key stereochemistry of
the quaternary carbon in the intermediate was built using
allylic substitution starting from a picolinate derived from
menthol.
The TBS-protected alcohol was also considered, but gave
lower conversions of substrate.
4.4 Spirocurcasone
The total synthesis of (−)-spirocurcasone was achieved by ring-
closing metathesis of a pentaene130 by Ito et al. in 2013
(Scheme 43). No protecting groups were required in the 9-step
procedure starting from (R)-perillaldehyde.
4.5 Sequosempervirin A
Sequosempervirin A is a novel spiro-norlignan compound iso-
lated in 2004 from the branches and leaves of the California
redwood Sequoia sempervirens.131 Three years later, the first
total synthesis of sequosempervirin A used ring-closing meta-
thesis as the spirocyclisation step leading to a cyclic allylic
alcohol en route to the final product132 (Scheme 44).
4.6 Chamigrenes: α-chamigrene, β-chamigrene,
laurencenones B and C and elatol
Other members of the chamigrene natural product family not
previously mentioned include β-chamigrene, laurencenone B
and elatol. The potent and varied biological activity of elatol
makes it a compound of significant interest. It has shown anti-
biofouling activity,133 anti-bacterial activity,134–136 anti-fungal
activity137 and cytotoxicity.138 It was isolated from red algae
Laurencia sp., as were laurencenones B and C. Like α-chami-
grene, β-chamigrene has been isolated from Schisandra chinen-
sis, although it was first isolated from the leaf oil of the
cypress Chamaecyparis taiwanensis.139
Scheme 41 Ring-closing metathesis in the synthesis of (+)-axenol.
Scheme 42 Ring-closing metathesis in the synthesis of (−)-axenol.
Scheme 43 Ring-closing metathesis in the synthesis of
spirocurcasone.
Scheme 44 Ring-closing metathesis during the synthesis of sequo-
sempervirin A.
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(±)-α-Chamigrene was synthesised from cyclohexenecar-
boxylic acid140 by Srikrishna et al. in 2006. The procedure used
an Ireland–Claisen rearrangement and ring-closing metathesis
as previously demonstrated by the same group in the synthesis
of (±)-isoacorone to give the product in 11 steps and 32%
overall yield (Scheme 45).
Racemic β-chamigrene and laurencenone C have been syn-
thesised by an Ireland–Claisen rearrangement, followed by
either ring-closing metathesis140 or an intramolecular type II
carbonyl ene reaction141 by Srikrishna et al. The metathesis
method required 11 steps to give the product in 32% overall
yield starting from a cyclohexenecarboxylic acid. For laurence-
none C, the initial method required 10 steps to give a 17%
overall yield.
(+)-Laurencenone B, (+)-elatol142 and (−)-laurencenone C143
have all been synthesised by ring-closing metathesis by Stoltz
et al. The starting material for both laurencenones was dime-
done. The synthesis required 7 steps to give the products in
34% and 31% overall yield respectively (Scheme 46). (+)-Elatol
required 9 steps to give the product in 11% overall yield.
This catalytic asymmetric method was generalised to the
chamigrene product family, using a palladium-based enantio-
selective decarboxylative allylation followed by ring-closing
metathesis.143
5. Diels–Alder reaction
The Diels–Alder reaction is a valuable tool in total synthesis,144
since it forms two carbon–carbon bonds and up to four stereo-
centres. Its application to the synthesis of spirocarbocycle-con-
taining natural products is described below.
5.1 Acoranes: colletoic acid, β-, γ-, δ-acoradienes, acorone
and isoacorone
For the avoidance of confusion, it should be noted that γ- and
δ-acoradiene are also known as α- and β-alaskene respectively,
due to their isolation from the Alaskan cedar, Chamaecyparis
nootkatensis.145,146
Retrosynthetic analysis of the acorane carbon skeleton
reveals that the cyclohexene can be broken into two units, of
which one is isoprene (Fig. 6).
γ- and δ-Acoradiene were synthesised by Marx et al. as early
as 1973147 using a method which was extended to β-acora-
diene, acorone, and isoacorone two years later148 (Scheme 47).
The starting material was (R)-pulegone, and a SnCl4-catalysed
Diels–Alder reaction was used. The major products were those
formed from the electronically favourable para orientation of
the reagents, whilst the minor products were formed from the
meta orientation. The Lewis acid increased selectivity for the
products of para cycloaddition. The reaction had been per-
formed without SnCl4, with heating to 100 °C and gave the
same products, in the ratio 45 : 25 : 20 : 10. The transition state
of the major isomer was formed by attack of the isoprene unit
on the opposite face to the methyl group, reducing unfavour-
able steric interactions, and eventually leading to the for-
mation of γ-acoradiene. The second isomer was formed by
attack of the isoprene on the same face as the methyl group,
which was then through further functionalisation converted to
δ-acoradiene.
Scheme 45 Ring-closing metathesis in the synthesis of racemic
α-chamigrene.
Scheme 46 Ring-closing metathesis in the synthesis of
(+)-laurencenone B and (+)-elatol.
Fig. 6 Retrosynthetic analysis of the carbon skeleton of colletoic acid.
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(+)-Colletoic acid is a sesquiterpenoid also from the acorane
family and a potent inhibitor of the 11β-hydroxysteroid type 1
enzyme, making it a therapeutic target for metabolic syn-
drome.149 This compound was generated as a single enantio-
mer in 2013 by a diastereoselective intramolecular 5-exo-Heck
reaction.150 At the same time, Nakada et al. used a stereo-
selective Lewis-acid catalysed Diels–Alder reaction with iso-
prene to create the spirocentre151,152 (Scheme 48). It was found
that the starting material for the Diels–Alder reaction decom-
posed at high temperatures, but when run at −20 °C in the
presence of the Lewis acid AlCl3, the reaction gave the desired
product as a single isomer.
5.2 Ainsliadimers A and B and gochnatiolides A–C
The ainsliadimers and gochnatiolides are a related set of
dimeric sesquiterpene lactones, biosynthesised from the
guaianolide dehydrozaluzanin C.
A biomimetic total synthesis of ainsliadimer A in 2010 by
Lei et al. proceeded in 14 steps, starting from α-santonin153
(Scheme 49). The key step was a hydrogen bond-promoted
[4 + 2]-hetero Diels–Alder dimerisation.
During an investigation into hydrogen bond donor cataly-
sis, hydrogen-bonding solvents were used but only chloroform
gave a trace amount of the dimer when the monomer was
heated at 35 °C for 12 h. Additives including triethylamine or
hydrochloric acid did not improve conversion, and longer reac-
tion times and higher temperatures led to increased decompo-
sition. Hydrogen bond donor catalysts were studied, and
racemic BINOL was found to be particularly eﬀective at catalys-
ing the dimerisation.
More recently, Qin et al. reported the total syntheses of
ainsliadimer B and gochnatiolides A and B which proceeded
in 25 steps and 1% overall yield using a cross Diels–Alder
cycloaddition154 (Scheme 50).
The Diels–Alder reaction could proceed via either an endo
or exo transition state, but only the product arising from the
endo transition state was observed. The exo transition state
would experience a high degree of steric interaction between
the silyl groups on the bottom face of the diene and the seven-
membered ring of the dehydrozazulin C. When attempted in a
variety of solvents, the reaction proceeded slowly to give the
Diels–Alder product in less than 15% yield and so the reaction
was run neat. Addition of acids such as ceric ammonium
sulfate, pyridinium p-toluenesulfonate, tosic acid and acetic
acid failed to catalyse the reaction, instead causing the
decomposition of the dehydrozaluzanin C product.
6. Claisen rearrangement
The Claisen rearrangement is a [3,3]-sigmatropic rearrange-
ment where an allyl vinyl ether is converted to an unsaturated
Scheme 47 Lewis-acid catalysed Diels–Alder reaction with isoprene in
the synthesis of γ- and δ-acoradienes.
Scheme 48 Lewis-acid catalysed Diels–Alder reaction in the synthesis
of (+)-colletoic acid.
Scheme 49 Hetero-[4 + 2] Diels–Alder reaction in the synthesis of ain-
sliadimer A.
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carbonyl.155,156 Its use in the synthesis of spiro sesquiter-
penoids has been recently reviewed by Kobayashi et al.157
6.1 Acoranes: acorone, isoacorone, α-acorenol and β-acorenol
As previously mentioned, (±)-acorone and (±)-isoacorone have
been formally synthesised by the Claisen rearrangement fol-
lowed by ring-closing metathesis. The Srikrishna group syn-
thesised racemic α-acorenol and β-acorenol employing this
strategy (see above).
6.2 Spirovetivanes: agarospirol, hinesol, β-vetivone and
α-vetispirene
(−)-Agarospirol,158,159 (+)-α-vetispirene, hinesol (an enantiomer
of agarospirol) and β-vetivone have all been synthesised by
the Kobayashi group using Claisen rearrangement methodo-
logies160,161 (Scheme 51).
6.3 Spiroaxanes: axenol, axisonitrile-3 and gleenol
Axisonitrile-3 is a nitrogenous sesquiterpenoid of interest due
to its significant biological activity, including anti-fouling
activity against barnacle larvae,162 cytotoxicity163 and potent
anti-malarial activity.164,165 It possesses an unusual isonitrile
group. Axenol is a key intermediate in its synthesis.
Racemic axenol and gleenol have been synthesised by the
Kobayashi group in 2007,166,167 applying the same methodo-
logy as for the synthesis of other spiro[4.5]decanes described
above.
Reduction and re-oxidation of the spiroketone gave a
mixture of enantiomers in the ratio 77 : 23, which were epi-
merised by treatment with ethanolic KOH and then separated
by column chromatography. Reduction with LiAlH4 gave a
mixture of racemic gleenol and axenol (Scheme 52).
A Claisen rearrangement was used by the same group to
synthesise (+)-axisonitrile-3 via (+)-gleenol and (−)-axamide-
3168 in 2009 (Scheme 53).
Scheme 50 Cross Diels–Alder via an endo intermediate in the syn-
thesis of ainsliadimer B and gochnatiolides A and B.
Scheme 51 Claisen rearrangement in the synthesis of agarospirol. The
intermediate 6.3 was present in >95% dr.
Scheme 52 Claisen rearrangement in the synthesis of (±)-gleenol and
(±)-axenol.
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6.4 Erythrodiene and spirojatamol
Eilbracht et al. reported a formal synthesis of erythrodiene and
spirojatamol which used a rhodium-based catalyst for a
tandem Claisen rearrangement-hydroacylation of an allyl vinyl
ether169 (Scheme 54). This method was also applied in 1996
for the synthesis of acoradienes and spirovetivanes as they
share the spiro[4.5]decanone skeleton.170
The acoradiene and spirovetivane procedure was performed
in one pot,171 and the particular rhodium catalyst chosen was
selected because it did not decompose at the required higher
temperatures and thus could catalyse the Claisen and hydro-
acylation reactions.172
7. Photochemical reaction
Photochemistry is a powerful tool used in total synthesis to
access products that can be otherwise diﬃcult to form. Its use in
natural product synthesis has been extensively reviewed.173–175
7.1 Acutumine
Acutumine is a tetracyclic alkaloid which shows selective T-cell
cytotoxicity and anti-amnesic properties.176
Castle et al. reported the first total synthesis of
(−)-acutumine in 2009, which utilised a photochemical
radical-polar crossover reaction to form the spirocycle177
(Scheme 55).
The cascade process was observed at 0 °C with a sun-lamp.
Optimisation experiments identified Et3Al as a more eﬀective
promoter than Et3B or Et2Zn, and 3-phenyl-2-(phenylsulfonyl)
oxaziridine as a better hydroxylating agent than oxygen, DMDO
or tBuOOH. Side-products were observed, with the alcohol
group replaced by an iodide or hydrogen. Attempts were made
to convert the iodide into the desired product by treatment with
diethyl zinc, oxygen and the oxaziridine gave the desired
product in 62% yield, thus increasing the overall yield to 66%.
Samarium diiodide/HMPA was considered as a replacement for
(Bu3Sn)2, but only gave a low yield of the desired product, and
led to the formation of many side-products. This was attributed
to the presence of functional groups in the starting material
that could react with SmI2. The mechanism still requires further
work to develop a better understanding.
Reisman et al. have attempted the synthesis of
(−)-acutumine via a photochemical [2 + 2]-cycloaddition, but
were only successful in constructing the aza-propellane
core.178 (−)-Acutumine has also been synthesised through a
Hosomi-Sakurai allylation in 17 steps179 by Herzon et al. in
2013.
Scheme 53 Claisen rearrangement in the synthesis of (+)-axisonitrile-
3. The dr of the intermediate 6.11 was >95%.
Scheme 54 Rhodium-catalysed Claisen rearrangement in the synthesis
of erythrodiene.
Scheme 55 Photochemical reaction in the synthesis of (−)-acutumine.
No diastereomers were observed.
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7.2 Acoranes: α-acorenol, β-acorenol, (−)-acorenone and
(±)-α-acoradiene
Photolysis was used in 1973 by Ramage et al. to stereospecifi-
cally synthesise (−)-α- and (+)-β-acorenol (Scheme 56).180
An enone [2 + 2] photocycloaddition was used in 1982 by
Baldwin et al. to synthesise (−)-acorenone181 (Scheme 57).
The key photochemical step was highly regio- and stereo-
specific, with the furanone reacting only in a head-to-tail
manner. (−)-Acorenone was synthesised in a total of 13 steps
in approximately 8% overall yield.
Irradiation of an enone was also used as the key step by
Oppolzer et al. in 1983 in the synthesis of racemic α-acora-
diene182 (Scheme 58).
The low yield was ascribed to the diﬃculty in separating the
various isomers produced by the radical reaction. Formation of
the diradical led to a loss of stereochemical information, and
resulted in the formation of two enantiomers, of which reduc-
tive fragmentation of only one gave the desired product.
7.3 Spirovetivanes: lubiminol, agarospirol, hinesol,
β-vetivone and α-vetispirene
Lubiminol is a spirovetivadiene phytoalexin isolated from
infected potatoes183,184 and the red pepper Capsicum
annuum.185
A double diastereoselective intramolecular photocycloaddi-
tion has been used to synthesise the spiro centre of lubiminol
(Scheme 59), followed by a radical fragmentation–rearrange-
ment reaction, on which Crimmins et al. have published a
series of articles.186–188
The reaction proceeded via a Dowd–Beckwith type ring
expansion to give the spirocyclic intermediate.
Takeshita et al. used photocycloaddition followed by a base-
catalysed benzilic acid rearrangement in 1995 to synthesise
racemic hinesol and agarospirol189 (Scheme 60).
As the rearrangement was not triggered using triethylamine
as a base, it was postulated that formation of a sodium che-
lated intermediate could assist in the rearrangement.
(−)-β-Vetivone has been synthesised by a dienone ring con-
traction of a spiro starting material with irradiation in acid to
form a spiroketone.45 Photolysis of a cross-conjugated diene
was used by Caine et al. to synthesise α-vetispirene190
(Scheme 61) in 1976.
Scheme 56 Photolysis in the synthesis of α-acorenol.
Scheme 57 Enone [2 + 2] photocycloaddition in the synthesis of
(−)-acorenone.
Scheme 58 Photochemical cyclobutane formation followed by reduc-
tive fragmentation in the synthesis of racemic α-acoradiene. The
conﬁgurations of 7.13 and 7.14 were not determined because this chiral-
ity was lost by reduction.
Scheme 59 Photocycloaddition during the synthesis of lubiminol.
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Glacial rather than aqueous acetic acid gave a dramatic
improvement in yield (28% to 89%), and a reduction in side-
product formation. The absence of water prevented hydrolysis
of the enol ether.
7.4 Proaporphines
The proaporphines are a major group of isoquinoline alka-
loids. They are biosynthetic precursors to aporphine alkaloids
which exhibit a broad range of biological activity.
Photolysis has been used by the Iwata and Fukumoto
groups. to synthesise pronuciferine,191,192 orientalinone,193
O-methyl-orientalinone,194 and O-methyl-kreysiginone195
(Scheme 62).
Pronuciferine has been synthesised using methyl vinyl
ketone in base,196 and more recently pronuciferine and ste-
pharine have been synthesised by aromatic oxidation with a
hypervalent iodine reagent.197 This led to the unprecedented
C–C bond formation between the para position of a phenol
and an enamide carbon.
7.5 Bilinderone and linderaspirone A
(±)-Bilinderone198 and (±)-linderaspirone A199 show promising
activity in the improvement of insulin sensitivity. Linderaspir-
one A is a highly symmetrical compound with a [4.3.4.3]
bispiro core, whereas bilinderone has a [4.5]spiro core.
Linderones have been synthesised biomimetically by Wang
et al. in 2011.200 The key step was a mild photochemical dimeri-
sation. (±)-Linderaspirone A was synthesised by a [2 + 2]-cyclo-
addition-Cope rearrangement (Scheme 63), whilst
Scheme 60 Photochemical reaction in the synthesis of racemic hinesol
and agarospirol.
Scheme 61 Photolysis in the synthesis of α-vetispirene.
Scheme 62 Photolysis of an intermediate in the synthesis of
pronuciferine.
Scheme 63 Photochemical dimerisation in the synthesis of linderaspir-
one A and bilinderone.
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(±)-bilinderone was synthesised by a [2 + 2]-cycloaddition-
radical rearrangement.
Irradiation of the neat starting material as a solid state
thin-film produced a mixture of products, including linder-
aspirone A, bilinderone, epi-bilinderone and an additional
side product containing an unusual spiro[3.4] system. Photo-
lysis in various solvents, including methanol, acetone, THF,
acetonitrile, toluene and benzene all gave yields of linder-
aspirone A and bilinderone in less than 20%.
In 2013, Hu et al. synthesised linderaspirone A in 3 steps as
well as bilinderone using a Darzens-type cyclopentadione reac-
tion (Scheme 64).201 The starting material was the same as was
used above.
When performed under oxygen rather than argon, the yield
of linderaspirone A increased from 38% to 50%.
8. Conclusions
Spirocarbocycles are important structural motifs found in
drugs, ligands and natural products, and so strategies towards
their challenging synthesis are key. This review has examined
several common reactions used to form these quaternary
centres, including the use of acid and base, particularly in the
aldol reaction. Ring-closing metathesis, the Diels–Alder reac-
tion, Claisen rearrangements and photochemistry have also
been used to synthesise these spirocarbocycles.
As seen above, the aldol reaction has been successful on
a wide range of carbon skeletons, although it lacks stereo-
selectivity unless the substrate already contains the desired
chirality. High yields are achievable with suitable starting
materials but if a mixture of products are obtained, the
eﬃciency decreases. This is similarly true for those reactions
eﬀected using acid or base, but since these do not operate
under one mechanism, it is diﬃcult to generalise. Stereo-
selectivity depends on both the reagents and the reaction
conditions: for example, the possibility of a 6-membered
chair transition state can increase selectivity. It is well-known
that ring-closing metathesis typically proceeds in excellent
yields and, like the Claisen rearrangement, is highly atom
eﬃcient. This also applies to the Diels–Alder reaction, which
can be chemo-, regio-, diastereo- and enantioselective. It is
important to note, however, that a substrate’s suitability for
these methods depends on its carbon skeleton and structure.
Finally, photochemical reactions are often not the obvious
first choice for many organic chemists, and as shown above,
their use is again highly substrate-dependent. It can be poss-
ible to get complex mixtures of products, but on occasion
high yields are achievable, as shown by several examples
above.
More work is required to develop new and improved routes
to these compounds and others in the literature that are yet to
be synthesised. As highlighted above, some natural products
with biological applications still require syntheses. Examples
of compounds discovered in the last ten years with biological
activity which are yet to be synthesised include biyouyana-
giol,202 spiromamakone A,203 and dibelamcandal A204 (Fig. 7).
Other natural products would benefit from more eﬃcient
routes, for example by the application of modern techniques
to improve selectivity in older methods. Whilst progress over
the last fifty years has been substantial, there is potential for
further synthesis and exploitation of natural products contain-
ing spirocarbocycles.
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Scheme 64 Photochemical reaction in the synthesis of linderaspirone
A.
Fig. 7 Unsynthesised natural products containing spirocarbocycles.
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